Home/Verndari/Amy Van Prooyen
AV

Amy Van Prooyen

Chief Executive Officer

Verndari

Therapeutic Areas

Verndari Pipeline

DrugIndicationPhase
VaxiPatch™ PlatformVaccine Delivery for Infectious DiseasesPre-clinical